Filter Results:
(762)
Show Results For
- All HBS Web
(1,408)
- People (2)
- News (339)
- Research (762)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
Show Results For
- All HBS Web
(1,408)
- People (2)
- News (339)
- Research (762)
- Events (2)
- Multimedia (5)
- Faculty Publications (389)
Sort by
- 01 Oct 2021
- Research & Ideas
Dying to Lead: How Reaching the Top Can Kill You Sooner
lifestyle, education, work environments, low employment turnover rates, and access to health care, I find higher-ranked employees at GE were more susceptible to a shorter lifespan,” Nicholas concludes in the paper. Job stress may vary by... View Details
Keywords: by Jay Fitzgerald
- 16 Jul 2020
- Research & Ideas
Restaurant Revolution: How the Industry Is Fighting to Stay Alive
the corporate health of their business, these are the companies that will uncover opportunities amidst the carnage that this crisis has brought. “I’m a contrarian,” said Pascal. “I actually think it’s a... View Details
- 26 Jun 2020
- Research & Ideas
Why Japanese Businesses Are So Good at Surviving Crises
bring different people together and spur them to action.” Their reward for thinking beyond profits? These businesses tend to live a long time. In fact, on a global map, Japan stands out for corporate longevity; 40 percent of companies... View Details
Keywords: by Dina Gerdeman
- April 2019
- Teaching Note
The a2 Milk Company
By: Benjamin C. Esty and Daniel Fisher
The a2 Milk Company (a2MC) became the most valuable company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow's milk. Because many people find the A1 protein difficult to digest, and... View Details
Keywords: Judo Economics; Market Entry; Innovation; Barriers To Response; Industry Attractiveness; Advantage Horizon; Sustainability; First-mover Advantage; Scope; Strategy Execution; Strategic Evolution; Biochemistry; Genetics; Branding; Commodity; Milk; Dairy; Infant Formula; Farming; Porter's Five Forces; Market Entry and Exit; Disruption; Innovation and Invention; Competitive Advantage; Corporate Strategy; Value Creation; Competition; Brands and Branding; Five Forces Framework; Consumer Products Industry; New Zealand; Australia; China
- 20 Mar 2018
- First Look
First Look at New Research and Ideas, March 20, 2018
Abstract—Firms spend millions of dollars annually on whistle-blower hotlines, training, and other efforts to ensure adherence to laws, regulations, and company policies. Yet malfeasance remains entrenched in the corporate world. Why? Too... View Details
Keywords: Sean Silverthorne
- January 2021 (Revised March 2021)
- Case
Serum Institute of India (SII): Racing to Save Lives During a Pandemic
By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how... View Details
Keywords: Business Ethics; Healthcare; COVID-19; Vaccines; Family Business; Ethics; Health Care and Treatment; Health Pandemics; Leadership; Corporate Accountability; Fairness; Growth and Development Strategy; Health Industry; India; South Asia
Deshpandé, Rohit, Anjali Raina, and Rachna Chawla. "Serum Institute of India (SII): Racing to Save Lives During a Pandemic." Harvard Business School Case 521-028, January 2021. (Revised March 2021.)
- October 1976 (Revised February 1987)
- Case
Cramer Electronics, Inc.
Designed to be the second day of a two-day series on the electronic component distribution industry, following a day spent discussing Note on the Electronic Component Distribution Industry and Raytheon Co.: Diversification. The important teaching themes which this case... View Details
Keywords: Change Management; Innovation Strategy; Management Style; Resource Allocation; Opportunities; Corporate Strategy; Diversification; Distribution Industry; Electronics Industry
Porter, Michael E. "Cramer Electronics, Inc." Harvard Business School Case 377-063, October 1976. (Revised February 1987.)
- April 2012
- Article
Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry
By: Jonathan R. Clark and Robert S. Huckman
The long-standing argument that focused operations outperform others stands in contrast to claims about the benefits of broader operational scope. The performance benefits of focus are typically attributed to reduced complexity, lower uncertainty, and the development... View Details
Keywords: Performance Capacity; Operations; Advertising; Production; Corporate Strategy; Relationships; Medical Specialties; Complexity; Risk and Uncertainty; Experience and Expertise; Diversification; Quality; Health Industry
Clark, Jonathan R., and Robert S. Huckman. "Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry." Management Science 58, no. 4 (April 2012): 708–722.
- April 2021
- Case
Coca-Cola: Preparing for the Next 100 Years
By: Cynthia A. Montgomery and James Weber
In early 2020, James Quincey, the 14th chair of the 133-year old The Coca-Cola Company, was in the midst of a years-long transformation of Coca-Cola from being the leading carbonated soft drink (CSD) beverage company into a total beverage company. The company’s... View Details
Keywords: Strategy; Diversification; Change Management; Organizational Culture; Environmental Sustainability; Food and Beverage Industry; United States
Montgomery, Cynthia A., and James Weber. "Coca-Cola: Preparing for the Next 100 Years." Harvard Business School Case 721-359, April 2021.
- 15 Jun 2010
- First Look
First Look: June 15
hiring and socialization policies. Institutional Demand Pressure and the Cost of Corporate Loans Authors:Victoria Ivashina and Zheng Sun Publication:Journal of Financial Economics (forthcoming) Abstract Between 2001 and 2007, annual... View Details
Keywords: Martha Lagace
- 14 Aug 2007
- First Look
First Look: August 14, 2007
prompting a takeover, than at engaging in long-term corporate governance or operating issues. Download the paper: http://www.hbs.edu/research/pdf/08-004.pdf Correlated Equilibrium and Nash Equilibrium as an Observer's Assessment of the... View Details
Keywords: Martha Lagace
- 17 Apr 2022
- Book
How to Avoid the 'Ethical Slide' That Leads Companies Astray
Good ethical practices don’t just happen; everyone within a corporation has to continuously work on them. “People are not always comfortable talking about ethics,” Nelson says. “Some have been dismissing ethics as, ‘I don’t have to think... View Details
Keywords: by Lane Lambert
- September 2009 (Revised May 2011)
- Case
Acumen Fund: Measurement in Impact Investing (A)
By: Alnoor Ebrahim and V. Kasturi Rangan
Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details
Keywords: Decision Choices and Conditions; Venture Capital; Investment Return; Philanthropy and Charitable Giving; Risk Management; Corporate Social Responsibility and Impact; Business and Government Relations; Social Enterprise; Financial Services Industry; Kenya
Ebrahim, Alnoor, and V. Kasturi Rangan. "Acumen Fund: Measurement in Impact Investing (A)." Harvard Business School Case 310-011, September 2009. (Revised May 2011.)
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
criminal justice reform, other issues like that, health care reform, but the nexus between corporate America and what Black America needs and the most, in my opinion, is employment. And so if we can do... View Details
- 09 May 2017
- First Look
New Research and Ideas, May 9
May 2017 Journal of Financial Economics The Value of Trading Relations in Turbulent Times By: Di Maggio, Marco, Amir Kermani, and Zhaogang Song Abstract—This paper investigates how dealers’ trading relationships shape their trading behavior in the View Details
Keywords: Sean Silverthorne
- 02 Sep 2014
- First Look
First Look: September 2
legacy labor and health care costs-is seriously incomplete and that GM's share collapsed for many of the same reasons that many of the other highly successful American firms of the 50s, 60s, and 70s were forced from the market, including... View Details
Keywords: Sean Silverthorne
- 15 Mar 2011
- First Look
First Look: March 15
system of expense allocation, and anti-inversion legislation—reflect the intuition that building "strong fences" around the United States advances American interests. This paper examines the interaction of a strong fences policy with the increasingly... View Details
Keywords: Sean Silverthorne
- 08 Mar 2004
- Research & Ideas
Creating Value in Your Business Ecosystem
Fundamentally, they aim to improve the overall health of their ecosystems by providing a stable and predictable set of common assets—think of Wal-Mart's procurement system and Microsoft's Windows operating system and tools—that other... View Details
Keywords: by Marco Iansiti & Roy Levien
- 2009
- Working Paper
Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry
By: Jonathan R. Clark and Robert S. Huckman
The long-standing argument that focused operations outperform others stands in contrast to claims about the benefits of broader operational scope. The performance benefits of focus are typically attributed to reduced complexity, lower uncertainty, and the development... View Details
Keywords: Health Care and Treatment; Medical Specialties; Performance Capacity; Diversification; Health Industry
Clark, Jonathan R., and Robert S. Huckman. "Broadening Focus: Spillovers, Complementarities and Specialization in the Hospital Industry." Harvard Business School Working Paper, No. 09-120, April 2009. (Revised April 2011.)
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.